Phenylpiracetam Hydrazide Tablets
|Molar Mass||218.256 g·mol−1|
Phenylpiracetam Hydrazine Tablets are an innovative research compound designed for scientific investigations, specifically focusing on its potential applications in neuroscience. It is imperative to emphasize that these tablets are intended solely for research purposes, and any mention of human consumption is strictly prohibited.
Phenylpiracetam Hydrazine is a derivative of phenylpiracetam, a well-known nootropic compound. This tablet formulation offers unique characteristics that make it suitable for research exploring its impact on neurotransmitters, brain function, and related areas of study.
Researchers utilize Phenylpiracetam Hydrazine Tablets as a tool to investigate its applications in neuroscience. The tablet form facilitates precise dosage control, enabling studies on its potential effects on neurotransmitter regulation, neurological disorders, and related research areas.
Phenylpiracetam Hydrazide and Dopamine
Studies suggest a potential link between Phenylpiracetam Hydrazine and dopamine regulation. The research aims to elucidate how the compound may influence dopamine levels in the brain, providing insights into its potential role in neurotransmitter modulation.
Phenylpiracetam Hydrazide and Potential Application on Stroke
Investigations explore the potential neuroprotective effects of Phenylpiracetam Hydrazine, particularly in the context of stroke. Researchers aim to understand its impact on neuronal health and recovery post-stroke, contributing to the development of novel therapeutic approaches.
Phenylpiracetam Hydrazide and Depression
The compound’s potential effects on mood and mental well-being are under scrutiny in studies related to depression. Research examines whether Phenylpiracetam Hydrazine may have antidepressant properties, shedding light on its potential applications in mental health research.
Phenylpiracetam Hydrazine Tablets offer a platform for research into its potential benefits, including dopamine regulation, neuroprotection post-stroke, and its impact on depressive-like conditions. As a research tool, this tablet formulation contributes to expanding our understanding of the compound’s effects on neurological processes.
- Urban KR, Gao WJ. Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain. Front Syst Neurosci. 2014 May 13;8:38. doi: 10.3389/fnsys.2014.00038. PMID: 24860437; PMCID: PMC4026746. [Read More].
- Koval’chuk VV, Skoromets AA, Koval’chuk IV, Stoianova EG, Vysotskaia ML, Melikhova EV, Il’iaĭnen EV. [Efficacy of phenotropil in the rehabilitation of stroke patients]. Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(12 Pt 2):38-40. Russian. PMID: 21626817. [Read More].
- Savchenko AIu, Zakharova NS, Stepanov IN. [The phenotropil treatment of the consequences of brain organic lesions]. Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(12):22-6. Russian. PMID: 16447562. [Read More].